The RT-MLPA assay was subsequently evaluated in a training cohort with CLL samples with known TP53 and ATM status, and support vector machine classifiers were constructed based on the FIs upon irradiation for a 10-gene panel. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.